Welcome to another edition of our weekly Ask D’Mine column! But before we get started, we want to wish Amy a very Happy Birthday today!
We hope Amy has a fabulous and relaxing day with her family and friends. She deserves it!
And now, back to our regularly scheduled programming…
;
Too much insulin, too little insulin… Goldilocks had nothing on PWDs! This week, our host Wil Dubois, diabetes author and community educator and also…
Read more »
If we had a dollar for every time “What the heck??” was uttered in managing diabetes, we’d probably have enough funds to find the cure ourselves! Luckily, we thrive on the never-ending mysteries of diabetes here at our weekly advice column, Ask D’Mine, hosted by veteran type 1, diabetes author and community educator Wil Dubois. This week, Wil tackles high BGs in a type 2 PWD, and how insulin-on-board is calculated differently in various insulin…
Read more »
Have you ever sat in a hot tub for too long and noticed your blood sugar starting to take a dive? When the skin heats up, blood vessels expand and allow for greater circulation, magnifying the impact of insulin and pushing glucose levels down — a fortunate effect that Israeli-based company InsuLine wants to duplicate in their new insulin delivery aid products, called the InsuPatch and InsuPad.
InsuLine, which we first reported on following a…
Read more »
It’s not too often we have a new insulin making its way on the scene, so we were excited to hear that Novo Nordisk filed two applications with the FDA for a new “ultra long acting” insulin called Degludec, and another for something called DegludecPlus, a combination of degludec and insulin aspart (Novolog), which would be available in an insulin pen in a fixed 70% degludec/30% Novolog ratio. The company is hoping for FDA approval…
Read more »
It’s no surprise to our readers that one of the biggest issues with current diabetes management is the lag time of our current fast-acting insulins.
Although light years ahead of what patients had in the past, current fast-acting insulins still aren’t quite up to snuff to handle post-prandial spikes. This is becomes a barrier for developing an Artificial Pancreas, as the insulin can’t respond quickly enough to sensor data in a closed-loop system.
The topic…
Read more »
